Universal Health Services cash flow, quarter by quarter
Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$422M in Q3 2026 · $1.1B over twelve months
Operating cash flow$637M
Capital spending−$215M
Free cash flow+$422M
Cash / net income2.0×
Analysis
In Q3 2026, Universal Health Services generated $637M of operating cash flow and spent $215M on capital projects, leaving free cash flow of $422M. That is $270M more than in Q3 2025 ($152M).
Over the twelve months to Sep 30, 2026, operating cash flow was $2.1B; the largest uses were buybacks ($1.1B), acquisitions ($1.0B), capital spending ($941M); besides operations, cash came from net borrowing (+) / repaid (−) ($1.0B), other investing ($44.9M); the cash balance rose by $86.0M.
Operating cash flow was $637M against net income of $313M — 2.0× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$175M, stock-based pay +$26.4M, other operating capital +$23.5M.
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $637M, Capital spending $215M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $7.1B; the largest uses were capital spending ($4.3B) and buybacks ($4.2B). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$169M
Debt$5.7B
Net debt$5.5B
Due within a year$749M
Universal Health Services funds itself: free cash flow was $1.1B over the last twelve months, and $169M of cash and investments stands against $5.7B of debt ($749M due within a year, 0.2× covered by cash).
Principal due in each year as disclosed in the annual report, against $169M of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Every quarter
Quarter
Operating cash flow
Capital spending
Acquisitions
Buybacks
Dividends
Net borrowing (+) / repaid (−)
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$637M
−$215M
−$998M
−$245M
−$11.8M
$873M
$4.3M
−$30.2M
$422M
Q2 2026
$443M
−$228M
—
−$321M
−$11.8M
$142M
$4.9M
−$19.8M
$216M
Q1 2026
$402M
−$217M
−$4.9M
−$164M
−$13.0M
−$45.2M
$3.8M
$18.8M
$184M
Q4 2025
$575M
−$281M
−$32K
−$352M
−$12.4M
$60.3M
$4.6M
−$54.7M
$293M
Q3 2025
$381M
−$229M
−$39.5M
−$237M
−$12.5M
$105M
$4.0M
$24.8M
$152M
Q2 2025
$549M
−$266M
—
−$155M
−$12.9M
−$68.0M
$4.5M
−$17.7M
$283M
Q1 2025
$360M
−$239M
−$8.3M
−$223M
−$13.5M
$143M
$3.7M
$1.0M
$121M
Q4 2024
$658M
−$246M
−$19.0M
−$250M
−$13.0M
−$169M
$4.2M
−$20.2M
$412M
Universal Health Services: income statement and cash flow
Universal Health Services, Q3 2026: revenue $4.7B (+5% year over year), operating margin 9.6%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.